AAAAAA
Results:
1-7
|
Results: 7
Authors:
JOSHI US
DERGHAM ST
CHEN YQ
DUGAN MC
CRISSMAN JD
VAITKEVICIUS VK
SARKAR FH
Citation: Us. Joshi et al., INHIBITION OF PANCREATIC TUMOR-CELL GROWTH IN CULTURE BY P21(WAF1) RECOMBINANT ADENOVIRUS, Pancreas, 16(2), 1998, pp. 107-113
Authors:
MOHAMMAD RM
DUGAN MC
MOHAMED AN
ALMATCHY VP
FLAKE TM
DERGHAM ST
SHIELDS AF
ALKATIB AA
VAITKEVICIUS VK
SARKAR FH
Citation: Rm. Mohammad et al., ESTABLISHMENT OF A HUMAN PANCREATIC TUMOR XENOGRAFT MODEL - POTENTIALAPPLICATION FOR PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC AGENTS, Pancreas, 16(1), 1998, pp. 19-25
Authors:
DUGAN MC
DERGHAM ST
KUCWAY R
SINGH K
BIERNAT L
DU W
VAITKEVICIUS VK
CRISSMAN JD
SARKAR FH
Citation: Mc. Dugan et al., HER-2 NEU EXPRESSION IN PANCREATIC ADENOCARCINOMA - RELATION TO TUMORDIFFERENTIATION AND SURVIVAL/, Pancreas, 14(3), 1997, pp. 229-236
Authors:
DERGHAM ST
DUGAN MC
ARLAUSKAS P
DU W
VAITKEVICIUS VK
CRISSMAN JD
SARKAR FH
Citation: St. Dergham et al., RELATIONSHIP OF FAMILY CANCER HISTORY TO THE EXPRESSION OF P53, P21(WAF-1), HER-2 NEU, AND K-RAS MUTATION IN PANCREATIC ADENOCARCINOMA/, International journal of pancreatology, 21(3), 1997, pp. 225-234
Authors:
DERGHAM ST
DUGAN MC
KUCWAY R
DU W
KAMARAUSKIENE DS
VAITKEVICIUS VK
CRISSMAN JD
SARKAR FH
Citation: St. Dergham et al., PREVALENCE AND CLINICAL-SIGNIFICANCE OF COMBINED K-RAS MUTATION AND P53 ABERRATION IN PANCREATIC ADENOCARCINOMA, International journal of pancreatology, 21(2), 1997, pp. 127-143
Authors:
DERGHAM ST
DUGAN MC
JOSHI US
CHEN YC
DU W
SMITH DW
ARLAUSKAS P
CRISSMAN JD
VAITKEVICIUS VK
SARKAR FH
Citation: St. Dergham et al., THE CLINICAL-SIGNIFICANCE OF P21(WAF1 CIP-1) AND P53 EXPRESSION IN PANCREATIC ADENOCARCINOMA/, Cancer, 80(3), 1997, pp. 372-381
Authors:
DUGAN MC
DERGHAM ST
KUCWAY R
VAITKEVICIUS VK
CRISSMAN JD
SARKAR FH
Citation: Mc. Dugan et al., MOLECULAR CLUES TO A NEW INTERPRETATION OF IN-SITU NEOPLASIA IN PANCREAS, Laboratory investigation, 74(1), 1996, pp. 781-781
Risultati:
1-7
|